Phase III trial of interferon-α-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. - Motzer,R.J.; Murphy,B.A.; Bacik,J.; Schwartz,L.H.; Nanus,D.M.; Mariani,T.; Loehrer,P.; Wilding,G.; Fairclough,D.L.; Cella,D.; Mazumdar,M. (J Clin Oncol, 2000)